Are biomarkers correlated with recurrence patterns in patients with resectable gastric adenocarcinoma

Molecular Biology Reports

Volumn 39, Issue 1, 2012, Pages 399-405

  Li, Gui Chao ^a   Zhang, Zhen ^a   Ma, Xue Jun ^a   Gu, Wei Lie ^a   Wang, Ya Nong ^a   Li, Jin ^a  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

Author keywords

Bio marker; D2 gastrectomy; Gastric cancer; Immunohistochemical (IHC); Prognosis; Recurrence pattern; Tumor marker

Indexed keywords

ALPHA FETOPROTEIN; CA 19-9 ANTIGEN; CA 242 ANTIGEN; CA 50 ANTIGEN; CA 72-4 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CYCLIN D1; CYCLINE; DNA TOPOISOMERASE (ATP HYDROLYSING); EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GLUTATHIONE TRANSFERASE P1; KI 67 ANTIGEN; MULTIDRUG RESISTANCE PROTEIN 1; MYC PROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P21; PROTEIN P27; PROTEIN P53; TUMOR MARKER;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER STAGING; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; GASTRECTOMY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROGNOSIS; RADIOIMMUNOASSAY; RECURRENCE RISK; RECURRENT DISEASE; STOMACH ADENOCARCINOMA; TREATMENT OUTCOME; TUMOR LOCALIZATION;

ADENOCARCINOMA; FEMALE; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; STOMACH NEOPLASMS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84855202929     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-011-0751-0     Document Type: Article

References (29)

1. DM Parkin F Bray J Ferlay P Pisani 2005 Global cancer statistics 2002 CA Cancer J Clin 55 74 108 15761078 10.3322/canjclin.55.2.74
2. CP Theuer T Kurosaki A Ziogas J Butler H Anton-Culver 2000 Asian patients with gastric carcinoma in the United States exhibit unique clinical features and superior overall and cancer specific survival rates Cancer 89 1883 1892 11064344 10.1002/1097-0142(20001101)89:9<1883::AID-CNCR3>3.3.CO;2-8 1:STN:280:DC%2BD3M%2FivFOluw%3D%3D
3. Y Noguchi T Yoshikawa A Tsuburaya H Motohashi MS Karpeh MF Brennan 2000 Is gastric carcinoma different between Japan and the United States? Cancer 89 2237 2246 11147594 10.1002/1097-0142(20001201)89:11<2237::AID-CNCR12>3.0. CO;2-9 1:STN:280:DC%2BD3M%2FosF2qsA%3D%3D
4. JS Macdonald SR Smalley J Benedetti SA Hundahl NC Estes GN Stemmermann DG Haller JA Ajani LL Gunderson JM Jessup JA Martenson 2001 Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction N Engl J Med 345 725 730 11547741 10.1056/NEJMoa010187 1:STN:280:DC%2BD3Mvps1Cqug%3D%3D
5. DH Roukos A Kappas 2005 Perspectives in the treatment of gastric cancer Nat Clin Pract Oncol 2 98 107 16264882 10.1038/ncponc0099 (Pubitemid 40790143)
6. DH Roukos S Murray E Briasoulis 2007 Molecular genetic tools shape a roadmap towards a more accurate prognostic prediction and personalized management of cancer Cancer Biol Ther 6 308 312 17387266 10.4161/cbt.6.3.3994 1:CAS:528:DC%2BD2sXhtVeqsbrN (Pubitemid 47328293)
7. DH Roukos 2008 Innovative genomic-based model for personalized treatment of gastric cancer: integrating current standards and new technologies Expert Rev Mol Diagn 8 29 39 18088228 10.1586/14737159.8.1.29 1:CAS:528:DC%2BD2sXhsVCgtr7P
8. Roukos DH (2002) HER2 and response to paclitaxel in node-positive breast cancer. N Engl J Med 358:197 (author reply 8)
9. RE Schwarz K Zagala-Nevarez 2002 Recurrence patterns after radical gastrectomy for gastric cancer: prognostic factors and implications for postoperative adjuvant therapy Ann Surg Oncol 9 394 400 11986192 10.1007/BF02573875 (Pubitemid 34496728)
10. J Landry JE Tepper WC Wood EO Moulton F Koerner J Sullinger 1990 Patterns of failure following curative resection of gastric carcinoma Int J Radiat Oncol Biol Phys 19 1357 1362 2262358 10.1016/0360-3016(90)90344-J 1:STN:280:DyaK3M%2Fos1Wntg%3D%3D
11. CH Yoo SH Noh DW Shin SH Choi JS Min 2000 Recurrence following curative resection for gastric carcinoma Br J Surg 87 236 242 10671934 10.1046/j.1365-2168.2000.01360.x 1:STN:280:DC%2BD3c7jslymsQ%3D%3D (Pubitemid 30088655)
12. M D'Angelica M Gonen MF Brennan AD Turnbull M Bains MS Karpeh 2004 Patterns of initial recurrence in completely resected gastric adenocarcinoma Ann Surg 240 808 816 15492562 10.1097/01.sla.0000143245.28656.15 (Pubitemid 39425773)
13. EY Shin BH Lee JH Yang 2000 Up-regulation and co-expression of fibroblast growth factor receptors in human gastric cancer J Cancer Res Clin Oncol 126 519 528 11003564 10.1007/s004320000128 1:CAS:528:DC%2BD3cXlsVWqsrg%3D
14. K Aoyagi K Kohfuji S Yano 2001 Evaluation of the epidermal growth factor receptor (EGFR) and c-erbB-2 in superspreading-type and penetrating-type gastric carcinoma Kurume Med J 48 197 200 11680933 10.2739/kurumemedj.48.197 1:CAS:528:DC%2BD3MXpt12qs78%3D (Pubitemid 33607408)
15. I Garcia F Vizoso A Andicoechea 2001 Clinical significance of epidermal growth factor receptor content in gastric cancer Int J Biol Markers 16 183 188 11605731 1:CAS:528:DC%2BD38XisVyktw%3D%3D (Pubitemid 33039924)
16. K Kofuji K Hashimoto I Kodama K Aoyagi J Ota J Takeda T Kakegawa 1993 Expression of the growth factors (EGF, EGFR, and TGF alpha) and PCNA in superspreading and penetrating types of gastric carcinomas Nippon Geka Gakkai Zasshi 4 8 92
17. EY Lee ML Cibull WE Strodel JV Haley 1994 Expression of HER-2/neu oncoprotein and epidermal growth factor receptor and prognosis in gastric carcinoma Arch Pathol Lab Med 8 235 239 (Pubitemid 24093646)
18. H Qin Y Sun EN Benveniste 1999 The transcription factors Sp1, Sp3, and AP-2 are required for constitutive matrix metalloproteinase-2 gene expression in astroglioma cells J Biol Chem 74 29130 29137 10.1074/jbc.274.41.29130 (Pubitemid 29477077)
19. SJ Price DR Greaves H Watkins 2001 Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene: role of Sp1 in allele-specific transcriptional regulation J Biol Chem 276 7549 7558 11114309 10.1074/jbc.M010242200 1:CAS:528:DC%2BD3MXislKns7Y%3D
20. SP Monig SE Baldus JK Hennecken DB Spiecker G Grass PM Schneider J Thiele HP Dienes AH Holscher 2001 Expression of MMP-2 is associated with progression and lymph node metastasis of gastric carcinoma Histopathology 39 597 602 11903578 10.1046/j.1365-2559.2001.01306.x 1:STN:280:DC%2BD387mvFyluw%3D%3D (Pubitemid 34017133)
21. JC Yao L Wang D Wei W Gong M Hassan TT Wu P Mansfield J Ajani K Xie 2004 Association between expression of transcription factor Sp1 and increased vascular endothelial growth factor expression, advanced stage, and poor survival in patients with resected gastric cancer Clin Cancer Res 10 4109 4117 15217947 10.1158/1078-0432.CCR-03-0628 1:CAS:528:DC%2BD2cXltFWmurc%3D (Pubitemid 38812490)
22. I Garcia F Vizoso A Martin L Sanz O Abdel-Lah P Raigoso JL Garcia-Muniz 2003 Clinical significance of the epidermal growth factor receptor and HER2 receptor in resectable gastric cancer Ann Surg Oncol 10 234 241 12679307 10.1245/ASO.2003.05.010 1:STN:280:DC%2BD3s7mtFOkuw%3D%3D (Pubitemid 40486955)
23. V Goral H Yesilbagdan A Kaplan D Sit 2007 Evaluation of CA 72-4 as a new tumor marker in patients with gastric cancer Hepatogastroenterology 54 1272 1275 17629087 1:CAS:528:DC%2BD2sXpsFGrsbk%3D (Pubitemid 47013952)
24. A Spila M Roselli M Cosimelli P Ferroni F Cavaliere R Arcuri M Tedesco S Carlini R D'Alessandro P Perri CU Casciani JW Greiner J Schlom F Guadagni 1996 Clinical utility of CA 72-4 serum marker in the staging and immediate post-surgical management of gastric cancer patients Anticancer Res 16 2241 2247 8694550 1:STN:280:DyaK28zhtlOlsw%3D%3D (Pubitemid 26265572)
25. JI Livingstone W Yasui E Tahara C Wastell 1995 Are Japanese and European gastric cancer the same biological entity? An immunohistochemical study Br J Cancer 72 976 980 7547252 10.1038/bjc.1995.445 1:CAS:528:DyaK2MXptlKjur0%3D
26. L Shen Z Liu L Xu X Sun S Wu 2010 Regulation of MMP-2 expression and activity by β-1,3-N-acetylglucosaminyltransferase-8 in AGS gastric cancer cells Mol Biol Rep 38 3 1541 1550 20963502 10.1007/s11033-010-0262-4
27. XR Luo JS Li Y Niu L Miao 2010 Targeted killing effects of double CD and TK suicide genes controlled by survivin promoter on gastric cancer cell Mol Biol Rep 38 2 1201 1207 20574710 10.1007/s11033-010-0218-8
28. CX Xu YF Yan YP Yang B Liu JX Xin SM Chen W Wang CY Jiang ZX Lu XX Liu 2010 Downregulation of ornithine decarboxylase by pcDNA-ODCr inhibits gastric cancer cell growth in vitro Mol Biol Rep 38 2 949 955 20533091 10.1007/s11033-010-0188-x
29. L Zhang H Huang K Wu M Wang B Wu 2010 Impact of BTG2 expression on proliferation and invasion of gastric cancer cells in vitro Mol Biol Rep 37 6 2579 2586 19728149 10.1007/s11033-009-9777-y 1:CAS:528:DC%2BC3cXosFCks7k%3D